# OnCo record paper-zhu-population-specific-immunogenomics-gallbladder-cancer-mod-pathol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-zhu-population-specific-immunogenomics-gallbladder-cancer-mod-pathol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-zhu-population-specific-immunogenomics-gallbladder-cancer-mod-pathol-2025" ;
  schema:name "Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance"@en ;
  schema:description "Gallbladder tumours from the United States and Chile carried the same set of mutated genes but very different immune cell make-up, which may bear on why immunotherapy helps only modestly and on how trials should be designed across regions."@en ;
  schema:url <https://onco.cc/key-papers/paper-zhu-population-specific-immunogenomics-gallbladder-cancer-mod-pathol-2025/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.modpat.2025.100824>, <https://pubmed.ncbi.nlm.nih.gov/40541865/> ;
  onco:tag "gallbladder-evidence" ;
  schema:sameAs <https://doi.org/10.1016/j.modpat.2025.100824> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Zhu Y, Solis Soto LM, Pant S, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/smad4/>, <https://onco.cc/targets/kras/>, <https://onco.cc/targets/pik3ca/>, <https://onco.cc/targets/arid1a/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/pd1/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-immunotherapy-response/> .